Discover
TMCI
Treace Medical Concepts, Inc.
4.49
2 x 3.34
2 x 5.74
bid
ask
-
0.04
0.88%
2 @ 07:30 PM
4.64 +0.15 (3.25%)
| Ytd | 83.27% | |
| 1y | -37.55% |
4.46
day range
4.68
1.20
52 week range
7.19
| Open | 4.57 | Prev Close | 4.53 | Low | 4.46 | High | 4.68 | Mkt Cap | 292.01M |
| Vol | 344.76K | Avg Vol | 551.69K | EPS | -0.92 | P/E | N/A | Forward P/E | -9.28 |
| Beta | 0.24 | Short Ratio | 3.26 | Inst. Own | 64.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 4.49 | 200-d Avg | 2.98 | 1yr Est | 7.96 |
| Income Statement | |||
| Total Revenue | 45.38M | ||
| Revenues (USD) | 45.38M | ||
| Cost of Revenue | 9.77M | ||
| Gross Profit | 35.61M | ||
| Operating Expenses | 50.57M | ||
| Research and Development Expense | 4.38M | ||
| Selling, General and Administrative Expense | 46.19M | ||
| Operating Income | -14.96M | ||
| Interest Expense | 1.56M | ||
| Net Income | -15.87M | ||
| Net Income Common Stock | -15.87M | ||
| Net Income Common Stock (USD) | -15.87M | ||
| Consolidated Income | -15.87M | ||
| Earnings per Basic Share | -0.24 | ||
| Earnings per Basic Share (USD) | -0.24 | ||
| Earnings per Diluted Share | -0.24 | ||
| Earning Before Interest & Taxes (EBIT) | -14.31M | ||
| Earning Before Interest & Taxes (USD) | -14.31M | ||
| Weighted Average Shares | 65.05M | ||
| Weighted Average Shares Diluted | 65.05M | ||
| Balance Sheet | |||
| Cash and Equivalents | 12.61M | ||
| Cash and Equivalents (USD) | 12.61M | ||
| Investments | 33.01M | ||
| Investments Current | 33.01M | ||
| Trade and Non-Trade Receivables | 28.73M | ||
| Current Assets | 120.45M | ||
| Property, Plant & Equipment Net | 39.64M | ||
| Total Assets | 181.06M | ||
| Total Debt | 69.13M | ||
| Current Liabilities | 41.50M | ||
| Debt Non-Current | 69.13M | ||
| Total Liabilities | 113.32M | ||
| Accumulated Retained Earnings (Deficit) | -282.83M | ||
| Accumulated Other Comprehensive Income | -52.00K | ||
| Shareholders Equity | 67.74M | ||
| Shareholders Equity (USD) | 67.74M | ||
| Assets Non-Current | 60.60M | ||
| Total Debt (USD) | 69.13M | ||
| Goodwill and Intangible Assets | 19.47M | ||
| Inventory | 39.54M | ||
| Liabilities Non-Current | 71.82M | ||
| Trade and Non-Trade Payables | 16.06M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.42M | ||
| Net Cash Flow from Financing | 696.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.07M | ||
| Capital Expenditure | -2.20M | ||
| Issuance (Purchase) of Equity Shares | 8.00K | ||
| Issuance (Repayment) of Debt Securities | 714.00K | ||
| Net Cash Flow from Investing | 7.07M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 9.27M | ||
| Net Cash Flow from Operations | -4.70M | ||
| Share Based Compensation | 6.46M | ||